Showing posts with label big pharma sells you. Show all posts
Showing posts with label big pharma sells you. Show all posts

Wednesday, October 3, 2012

Valium’s Contribution to Our New Normal





IT wasn’t funny, really, but everybody laughed at the scene in the 1979 film “Starting Over” when Burt Reynolds’s character had a panic attack in the furniture department of Bloomingdale’s (something to do with terror at the prospect of buying a couch). “Does anyone have a Valium?” his brother called out as Burt hyperventilated. The punch line: Every woman in the store reached into her purse and pulled out a little vial of pills.
Nor was it surprising that all those Bloomie’s shoppers could be so helpful, since by that time Valium, which had been introduced in 1963, was the best-selling prescription drug in America, with billions of blue or yellow or white pills, each stamped with a trademark V, sold every year.
Valium was, significantly, one of the first psychoactive drugs to be used on a large scale on people who were basically fine. It has since been surpassed by other drugs, like the popular tranquilizer Xanax. But with the pharmaceutical giant Roche announcing that it will soon close the Nutley, N.J., plant where Valium and its predecessor, Librium, were developed, it’s a good time to remember how revolutionary these “minor tranquilizers” were half a century ago. These were the drugs that gave us a new way to slay our inner demons, medicating our way to a happier life.
How did Roche convince physicians that it was O.K. to offer their patients a bottled form of serenity? How did the physicians persuade their patients? And how did the company’s success in this venture shape our collective attitudes toward normal versus abnormal, stoic versus foolhardy, and the various ways available to cope with the ups and downs of daily life?
Marketing, essentially — which was first put into action with Librium, one of those evocative drug names that pharmaceutical companies invent. Librium was introduced in 1960 and promptly outsold its predecessors, the barbiturates, because it had fewer side effects. (Barbiturates were serious downers, making people sleepy and zombielike, and they were habit-forming; Marilyn Monroe died from an overdose.)
“A Whole New World ... of Anxiety” read one of the early Roche ads for Librium, featuring a young woman with a pageboy hairdo holding an armload of books, wearing a short stadium coat and heading off to college. The copy made it sound as though every step in this “whole new world” called out for a tranquilizer. “The new college student may be afflicted by a sense of lost identity in a strange environment ... Her newly stimulated intellectual curiosity may make her more sensitive to and apprehensive about unstable national and world conditions.”

Wednesday, March 17, 2010

Fluoride & the Kidneys


Fluoride & the Kidneys

Kidney disease markedly increases an individual's susceptibility to fluoride toxicity.

The kidneys are responsible for ridding the body of ingested fluoride, and thereby preventing the buildup of toxic levels of fluoride in the body.

In healthy adults, the kidneys are able to excrete approximately 50% of an ingested dose of fluoride.

However, in adults with kidney disease the kidneys may excrete as little as 10 to 20% of an ingested dose - thus increasing the body burden of fluoride and increasing an individual's susceptibility to fluoride poisoning (e.g. renal osteodystrophy).

The bone changes commonly found among patients with advanced kidney disease closely resemble the bone changes found among individuals with the osteomalacic-type of skeletal fluorosis. This raises the possibility that some individuals with kidney disease are suffering from undiagnosed skeletal fluorosis.

As noted by Dr. Edward Groth, a veteran Senior Scientist at Consumers Union:

"It seems probable that some people with severe or long-term renal disease, which might not be advanced enough to require hemodialysis, can still experience reduced fluoride excretion to an extent that can lead to fluorosis, or aggravate skeletal complications associated with kidney disease... It has been estimated that one in every 25 Americans may have some form of kidney disease; it would seem imperative that the magnitude of risk to such a large sub-segment of the population be determined through extensive and careful study. To date, however, no studies of this sort have been carried out, and none is planned" (Groth 1973; Doctoral Thesis; Stanford University).

Because the kidney accumulates more fluoride than all other soft tissues (with the exception of the pineal gland), there is concern that excessfluoride exposure may contribute to kidney disease - thus initiating a "vicious cycle" where the damaged kidneys increase the accumulation of fluoride, causing in turn further damage to the kidney, bone, and other organs.

The possibility that fluoride exposure can cause direct damage to kidney tissue is supported by a long line of animal and human studies.

In studies on fluoride-exposed animals, kidney damage has been reported at levels as low as 1 ppm if the animals consume the water for long periods of time.

In humans, elevated rates of kidney damage are frequently encountered among populations with skeletal fluorosis. In addition, several case reports suggest that some individuals with kidney disease can experience significant recovery in their clinical signs and symptoms following the provision of fluoride-free water.






Acknowledgement: http://www.fluoridealert.org/health/kidney/

Monday, December 28, 2009

Video - Selling Sickness



Click on video to go directly to YouTube for faster access...